More questions than answers: antihistamines' link to cancer.
Robinson
A
A
D000818:Animals; D016589:Astemizole / Q000009:adverse effects; D002170:Canada; D004305:Dose-Response Relationship, Drug; D004345:Drug Industry; D005354:Fibrosarcoma / Q000209:etiology* / Q000503:physiopathology; D006633:Histamine Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology; D006919:Hydroxyzine / Q000009:adverse effects; D017336:Loratadine / Q000009:adverse effects; D008546:Melanoma, Experimental / Q000209:etiology* / Q000503:physiopathology; D051379:Mice; D010647:Phenyl Ethers / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D013629:Tamoxifen / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D014481:United States; D014486:United States Food and Drug Administration
D006633:Histamine Antagonists; D006634:Histamine H1 Antagonists; D010647:Phenyl Ethers; D013629:Tamoxifen; D006919:Hydroxyzine; D017336:Loratadine; D016589:Astemizole; C043062:tesmilifene